India&#39;s Ranbaxy Pulls All AIDS Drugs from WHO List
609763
Indian firm Ranbaxy took all its anti-AIDS drugs off the UN&#39;s approved list, the World Health Organization said on Tuesday, dealing a blow to efforts to make cheaper
688083
GlaxoSmithKline Plc cut the prices on its range of HIV drugs offered to developing countries, marking the fifth such discount since 1997.
260413
Some of the 4,450 patients enrolled in a large clinical study have dropped out because of safety concerns about Avandia.
470170
Geneva: India&#39;s top pharmaceutical group Ranbaxy has withdrawn all its anti-retroviral drugs from a World Health Organisation scheme setting minimum quality standards for cheaper anti-AIDS medication aimed at poor countries, the WHO said Tuesday.
177254
FOLLOWING Ranbaxy Laboratories&#39; decision to withdraw all its anti-retroviral (ARV) drugs from the World Health Organisation (WHO) list, the Health Ministry is concerned about this development and is likely to ask the Drugs Controller General of India (DCGI
439981
THE Ministry of Health yesterday urged Jamaicans to immediately discontinue the use of the arthritis drug Vioxx (refecoxib), which was pulled off the market yesterday by its manufacturer Merck &amp; Co.
228288
The campaign to get cheap Aids drugs to millions of Africans was dealt a blow yesterday when a manufacturer in India admitted it could not prove the quality of its medicines and withdrew them from the list approved by the World Health Organisation.
660534
The world&#39;s biggest AIDS conference  closed on Wednesday with a call for the development of  child-specific drugs to ensure millions of HIV-infected  children not only survive to adulthood, but also live without  damaging side effects from their treatment.
529230
Following an inspection by the World Health Organization (WHO), Indian generic manufacturer Hetero Drugs is withdrawing six antiretrovirals from the WHO prequalification list in order to review data on their bioequivalence.
238759
Researchers have halted two studies of an anti-AIDS vaginal gel in Africa and India after early results suggested it might raise the risk of HIV infection instead of lowering it.
564970
India&#39;s Ranbaxy Laboratories said Wednesday it&#39;s developed a new anti-malarial drug, claiming it would cost less but work as well as drugs now used for the disease that kills more than a million people a year worldwide.
625211
The health ministry has acknowledged that it asked for references to the Treatment Action Campaign (TAC) and gays to be removed from a series of Aids guides.
472264
Another Indian generic drug manufacturer, Hetero Drugs, has withdrawn six of its anti-AIDS medicines from the World Health Organisation&#39;s (WHO) prequalification list.
241801
An Indian pharmaceutical company, Ranbaxy, has withdrawn of ten of its generic AIDS drugs after an investigation revealed flaws in research claiming the drugs were as effective as patented ones.
263867
India-based Hetero Drugs has withdrawn all six of its antiretroviral drugs from the WHO&#39;s list of approved drugs following concerns about their laboratory tests, the World Health Organisation (WHO) said on Friday.
710327
New Delhi: The World Health Organisation(WHO) has said that it would consider re-enlisting the remaining three of the five banned aids drugs manufactured in India if the laboratories producing them meet the set international standards.
78500
India's Ranbaxy Laboratories Ltd. has received the U.S. Food and Drug Administration's approval for clarithromycin, a generic form of Abbott Laboratories Inc.'s antibiotic Biaxin, the FDA said on Saturday.